Lexicon Pharmaceuticals (LXRX) Tax Provisions (2010)
Lexicon Pharmaceuticals (LXRX) posted quarterly Tax Provisions of -$26000.0 for Q3 2010.
Lexicon Pharmaceuticals (LXRX) Tax Provisions (2010) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Tax Provisions for 1 consecutive years, with -$26000.0 the latest figure, recorded in Q3 2010.
- In Q3 2010, Tax Provisions changed N/A year-over-year to -$26000.0; the TTM figure through Dec 2011 stood at -$26000.0 (changed N/A YoY), while the FY2014 annual figure was -$70000.0, changed N/A from the prior year.
- Tax Provisions held at -$26000.0 in Q3 2010 per LXRX's latest filing.
- Across five years, Tax Provisions topped out at -$26000.0 in Q3 2010 and bottomed at -$26000.0 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | -26,000.00 |